T. Rowe Price Associates’s 908 Devices MASS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$178K Buy
20,387
+1,002
+5% +$7.7K ﹤0.01% 3038
2026
Q1
$119K Buy
19,385
+5,558
+40% +$34.8K ﹤0.01% 2960
2025
Q4
$73K Hold
13,827
﹤0.01% 2991
2025
Q3
$122K Buy
13,827
+1,417
+11% +$9.42K ﹤0.01% 2893
2025
Q2
$89K Hold
12,410
﹤0.01% 2913
2025
Q1
$56K Buy
+12,410
New +$36.8K ﹤0.01% 2910
2021
Q2
Sell
-465,287
Closed -$22.6M 2942
2021
Q1
$22.6M Sell
465,287
-107,713
-19% -$6.16M ﹤0.01% 1251
2020
Q4
$32.6M Buy
+573,000
New +$33.5M ﹤0.01% 1091

Other funds holding MASS

T. Rowe Price Associates's MASS Position: Q2 2026 in Review

T. Rowe Price Associates increased its 908 Devices (MASS) stake by 5.2% in Q2 2026, buying an estimated $7.7K and bringing the position to 20,387 shares worth $178K. The position accounts for ﹤0.01% of the portfolio, ranked #3038.

T. Rowe Price Associates first reported a position in MASS in Q4 2020 and has held it in 8 quarters since. The position peaked at $32.6M in Q4 2020. 112 funds tracked by Wall St. Rank hold MASS as of Q2 2026.

  • T. Rowe Price Associates held 20,387 shares of 908 Devices worth $178K as of Q2 2026.
  • T. Rowe Price Associates bought 1,002 908 Devices shares in Q2 2026, an estimated $7.7K.
  • 908 Devices made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #3038 holding.
  • T. Rowe Price Associates first reported a position in 908 Devices in Q4 2020 and has held it in 8 quarters since.
  • T. Rowe Price Associates's 908 Devices position peaked at $32.6M in Q4 2020.
  • 112 funds tracked by Wall St. Rank held 908 Devices as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.